Company: FCRS
Filing Date: 2025-09-26
Form Type: 424B4
Source: 0001213900-25-092098
Chunk: 145

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-26
Form: 424B4
Chunk 145
---
     |            |           — |   |     |                |  (6,250,000 | ) |     |            |  (7,187,500 | ) |     |                |  (12,500,000 | ) |     |            |  (14,375,000 | ) |     |                |  (18,750,000 | ) |     |            |  (21,562,500 | ) |     |               |  (25,000,000 | ) |     |            |  (28,750,000 | ) |
|                                                                                                      |     |               |  31,250,000 |   |     |            |  35,937,500 |   |     |                |  25,000,000 |   |     |            |  28,750,000 |   |     |                |   18,750,000 |   |     |            |   21,562,500 |   |     |                |   12,500,000 |   |     |            |   14,375,000 |   |     |               |    6,250,000 |   |     |            |    7,187,500 |   |

____________ (1)Expenses applied against gross proceeds include offering expenses of approximately $750,000 and underwriting commissions of $0.20 per unit (including any units sold pursuant to the underwriters’ option to purchase additional units), or $5,000,000 in the aggregate, payable to Cantor Fitzgerald & Co (excluding deferred underwriting commissions). See “ Use of Proceeds.” (2)Upon the consummation of our initial business combination, the deferred underwriting commissions would be paid as follows: $0.40 per unit on units other than those sold pursuant to the underwriters’ option to purchase additional units and $0.60 per unit on units sold pursuant to the underwriters’ option to purchase additional units, or $10,000,000 in the aggregate or up to $12,250,000 in the aggregate if the underwriters’ over -allotmentoption is exercised in full payable to Cantor Fitzgerald & Co, for deferred underwriting commissions. See also “ Underwriting” for a description of compensation and other items of value payable to the underwriters. (3)If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our